Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Europe is the largest consumption market, with a sales volume share of about 35.74% in 2019. Following Europe, North America ranks the second with 27.27%.
The Prostaglandin is classified into the human prostaglandin and veterinary prostaglandin according to the product type. As of 2019, human prostaglandin segment dominates the market contributing more than 87% of the total revenue.
Prostaglandin is major treat for ophthalmologic, cardiovascular, gynecological and obstetrical and other departments. Ophthalmologic occupied about 42.76% of the market.
The Prostaglandin market is relative concentrated market, with key players Sanofi CEPiA, Kyowa Hakko Pharma, Cayman Chemical, Yonsung Fine Chemicals, Johnson Matthey, Chirogate, Everlight Chemical, ANVI Pharma, AUSUN Pharmaceutical, Aspen Biopharma Labs and others. Sanofi CEPiA is the largest player who owned more than 20% of the revenue share in 2019.

Market Analysis and Insights: Global Prostacyclin Market
The global Prostacyclin market was valued at US$ 483.4 in 2020 and will reach US$ 729.6 million by the end of 2027, growing at a CAGR of 7.1% during 2022-2027.

Global Prostacyclin Scope and Market Size
The global Prostacyclin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostacyclin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Human Prostaglandin
Veterinary Prostaglandin

Segment by Application
Ophthalmologic
Cardiovascular
Gynecological and Obstetrical
Others

The Prostacyclin market is analysed and market size information is provided by regions (countries). Segment by Application, the Prostacyclin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs